Discovery of 'creator' gene for cerebral cortex points to potential stem cell ...(hing implications in the nascent field o...)

Date:1/17/2008

hing implications in the nascent field of stem cell research. The Monuki lab is currently studying how to activate Lhx2 genes in neural stem cells and initiate the process in which new cortical cells can grow. If successful, the concept of using Lhx2 to instill stem cells with cortical properties could be a basis of clinical studies that could one day help treat patients, he said.

Researchers in Monukis lab are deeply involved with stem cell research. Last month, they published a study identifying a new way to sort stem cells that should be quicker, easier and more cost-effective than current methods. The technique could in the future expedite therapies for people with conditions ranging from brain and spinal cord damage to Alzheimers and Parkinsons diseases.

'/>"/>

Contact: Tom Vasich tmvasich@uci.edu 949-824-6455 University of California - Irvine Source:Eurekalert

0 GOOD

Page: 1 2
Related biology technology :

1. ARCA Discovery, Inc. to Present at 26th Annual JPMorgan Healthcare Conference on January 8, 2008
2. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
3. Vaccinex, Inc. Announces Award of Key Patent in Europe for its Antibody Discovery Technology (ActivMab(R))
4. Discovery Institute Bioethicist Lauds Breakthrough in Stem Cells Research that Eliminates Need for Human Cloning
5. Discovery of a new way to manipulate light a million times more efficiently
6. Senomyx Announces Conclusion of Discovery and Development Collaboration With Kraft Foods Global, Inc.
7. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
8. EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference
9. Senex Biotechnology Announces Presentation of Alzheimers Disease Drug Discovery Effort
10. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
11. New method of selecting DNA for resequencing accelerates discovery of subtle DNA variations